Accuracy Coverage Pricing Contact

AstraZeneca maintain dividend at $0.90

Investment Tools Ltd.
AstraZeneca maintain dividend at $0.90

Following recommendation from the board, AstraZeneca have maintained their dividend at $0.90.

Other financial highlights include:

- Product Sales increased by 12% in the half (17% at CER) to $11,183m

- The Reported Gross Margin increased by two percentage points in the half to 80%, partly reflecting the mix of Product Sales and manufacturing efficiencies; the Core Gross Margin increased by one percentage point to 81%

- Reported Operating Expenses increased by 5% in the half (10% at CER) to $8,238m and represented 73% of Total Revenue (H1 2018: 76%). Core Operating Expenses increased by 1% (5% at CER) to $6,922m and represented 61% of Total Revenue (H1 2018: 67%), demonstrating operating leverage

- Reported R&D Expenses declined by 1% (an increase of 3% at CER) to $2,622m. Core R&D Expenses declined by 2% (an increase of 2% at CER) to $2,505m

- Reported SG&A Expenses increased by 9% (14% at CER) to $5,457m; Core SG&A Expenses increased by 3% (7% at CER) to $4,258m, primarily reflecting growth in China, as well as ongoing additional support for new medicines

- Reported Other Operating Income and Expense declined by 35% in the half (34% at CER) to $706m; Core Other Operating Income and Expense increased by 1% (2% at CER) to $708m; in the second quarter, Core Other Operating Income and Expense declined by 80% to $114m

- The Reported Operating Margin was stable in the half at 14%; the Core Operating Margin increased by six percentage points (five at CER) to 27%

- Reported EPS of $0.56 in the half, based on a weighted-average number of shares of 1,289m, represented an increase of 3% (stable at CER); Core EPS increased by 38% (40% at CER) to $1.62. The difference between the Reported and Core performance partly reflected the impact of a favourable $346m legal settlement in H1 2018, recognised as income in Reported Other Operating Income and Expense, as well as the commencement of the amortisation of Lokelma and fair-value adjustments arising on acquisition-related liabilities recognised in Reported SG&A Expense in Q2 2019

- The Reported Tax Rate was 25% (H1 2018: 19%); the Core Tax Rate was 21% (H1 2018: 19%). The tax rates in the half reflected the geographical mix of profits and the impact of collaboration and divestment activity

Companies mentioned

Latest News

Investment Tools Limited

GVC declare they will pay an interim dividend of 17.6p, reflecting an increase of 10% compared to last year, and in-line with the new policy of double-digit year-on-year increases.

Read more
Investment Tools Limited

The Board has declared an interim dividend of 4.0 US cents per share in respect of the first half of 2019, down from 6.0 US cents. KAZ Minerals PLC, the parent company of the Group, is a non-trading investment holding company and derives its profits from dividends paid by subsidiary companies.

Read more
Investment Tools Limited

The  Marshalls board has declared an interim dividend of 4.70 pence (2018: 4.00 pence) per share, an increase of 18 per cent, reflecting the strong cash generation and the Group's continuing progressive dividend policy. The Board will continue to adhere to the Group's capital allocation policy and the policy of maintaining a 2 times dividend cover.

Read more
Investment Tools Limited

Clarkson have increased their dividend by 1p per share to 25p per share. The Company has now delivered 16 years of consecutive dividend growth.

Read more
Investment Tools Limited

The Board of Hargreaves Lansdown has declared a 2019 total ordinary dividend of 33.7 pence per share (2018: 32.2p), 5% ahead of last year. This is in line with EPS growth and maintains the ordinary dividend payout ratio at 65%. In addition, the Board has declared a special dividend of 8.3 pence per share (2018: 7.8p). The 2019 total dividend of 42.0 pence per share (2018: 40.0p) is up 5% and results in a total dividend payout ratio of 80.6% (2018: 80.6%). Subject to shareholder approval of the final dividend at the 2019 AGM, the final and special dividends will be paid on 18 October 2019 to all shareholders on the register at the close of business on 27 September 2019.

Read more
Investment Tools Limited

Evraz has announced interim dividend for 2019 of US$508.17m (US$0.35 per share) has been declared, reflecting the Board's confidence in the Group's financial position and outlook.

Read more
Investment Tools Limited

The Savills Board has declared an interim dividend of 4.95p per share (2018: 4.8p), supported by the performance of the Group's less transactional businesses. The interim dividend of 4.95p per share will be payable on 2 October 2019 to shareholders on the register on 5 September 2019.

Read more
Investment Tools Limited

ContourGlobal have proposed quarterly dividend of USD 3.6901 cents per share, equivalent to $24.75 million, reflecting their commitment to 10% year on year dividend growth supported by ContourGlobal's strong and predictable cash flow generation. 

Read more
Investment Tools Limited

Arrow Global will pay a 4.4p interim dividend, an increase of 10% from the H1 2018 interim dividend of 4.0p. This is in line with the Group's policy to pay 50% of the previous year's final dividend.

Read more
Investment Tools Limited

Derwent London have raised their interim dividend by 9.9% to 21.00p from 19.10p per share in 2018

Read more
More News